These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 303866)
41. Recovery of the human early receptor potential during dark adaptation in hereditary retinal disease. Berson EL; Goldstein EB Vision Res; 1970 Mar; 10(3):219-26. PubMed ID: 5311448 [No Abstract] [Full Text] [Related]
42. Rod and cone contributions to the human early receptor potential. Goldstein EB; Berson EL Vision Res; 1970 Mar; 10(3):207-18. PubMed ID: 5453511 [No Abstract] [Full Text] [Related]
43. Visual function and rhodopsin levels in humans with vitamin A deficiency. Kemp CM; Jacobson SG; Faulkner DJ; Walt RW Exp Eye Res; 1988 Feb; 46(2):185-97. PubMed ID: 3350064 [TBL] [Abstract][Full Text] [Related]
44. The relation of rhodopsin and scotopic retinal sensitivity in sector retinitis pigmentosa. Fulton AB; Hansen RM Am J Ophthalmol; 1988 Feb; 105(2):132-40. PubMed ID: 3341429 [TBL] [Abstract][Full Text] [Related]
45. Two types of visual dysfunction in autosomal dominant retinitis pigmentosa. Kemp CM; Jacobson SG; Faulkner DJ Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1235-41. PubMed ID: 3417410 [TBL] [Abstract][Full Text] [Related]
46. Rod ERG diurnal rhythm in some patients with dominant retinitis pigmentosa. Sandberg MA; Baruzzi CM; Hanson AH; Berson EL Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):494-8. PubMed ID: 3343106 [TBL] [Abstract][Full Text] [Related]
47. Temporal aspects of the dark-adapted cone a-wave in retinitis pigmentosa. Sandberg MA; Sullivan PL; Berson EL Invest Ophthalmol Vis Sci; 1981 Nov; 21(5):765-9. PubMed ID: 7298280 [TBL] [Abstract][Full Text] [Related]
48. Electroretinographic responses following vitamin A therapy in A-beta-lipoproteinemia. Sperling MA; Hiles DA; Kennerdell JS Am J Ophthalmol; 1972 Mar; 73(3):342-51. PubMed ID: 4536856 [No Abstract] [Full Text] [Related]
49. Rod and cone activity in patients with dominantly inherited retinitis pigmentosa: comparisons between psychophysical and electroretinographic measurements. Arden GB; Carter RM; Hogg CR; Powell DJ; Ernst WJ; Clover GM; Lyness AL; Quinlan MP Br J Ophthalmol; 1983 Jul; 67(7):405-18. PubMed ID: 6860608 [TBL] [Abstract][Full Text] [Related]
50. Serial ERG monitoring of response to therapy in vitamin A deficiency related night blindness. Poornachandra B; Jayadev C; Sharief S; Shetty R BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35351751 [TBL] [Abstract][Full Text] [Related]
51. Rod ERGs in retinitis pigmentosa and cone-rod degeneration. Birch DG; Fish GE Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):140-50. PubMed ID: 3804644 [TBL] [Abstract][Full Text] [Related]
52. Vitamin A supplementation for retinitis pigmentosa. Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFrano C; Willett W Arch Ophthalmol; 1993 Nov; 111(11):1456-9. PubMed ID: 8240091 [No Abstract] [Full Text] [Related]
53. The relationship between rod perimetric thresholds and full-field rod ERGs in retinitis pigmentosa. Birch DG; Herman WK; deFaller JM; Disbrow DT; Birch EE Invest Ophthalmol Vis Sci; 1987 Jun; 28(6):954-65. PubMed ID: 3583634 [TBL] [Abstract][Full Text] [Related]